Herbalife Analyst Price Targets - Benzinga

Herbalife Ltd

HLFNYSE

Trade with Public

Trade with Public

$12.45

-0.10-0.81%

最終更新: Sep 28, 7:46 AM

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Herbalife Analyst Price Targets

Wall Street analyst price targets and consensus rating for Herbalife (HLF).

Price Target Range — 12 Quarters

Analyst Consensus — 8 Analysts

5Buy

2Hold

1Sell

Consensus RatingBuy# Analysts8Avg. Consensus PT$15Upside to Avg. PT+17.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	Citigroup	Chasen Bender	PT Cut	Buy	$21→$17
Apr 28, 2026	RBC Capital	Ryland Conrad	PT Cut	Sector Perform	$17→$16
Mar 30, 2026	Mizuho	John Baumgartner	PT Raise	Neutral	$13→$15
Feb 19, 2026	Citigroup	Chasen Bender	PT Raise	Buy	$17→$21
Jan 8, 2026	Mizuho	John Baumgartner	PT Raise	Neutral	$11→$13
Jan 6, 2026	Maxim Group	Anthony Vendetti	Initiate	Buy	$20
Dec 12, 2025	Citigroup	Chasen Bender	PT Raise	Buy	$11→$17
Nov 26, 2025	Mizuho	John Baumgartner	PT Raise	Neutral	$10→$11
Nov 26, 2025	Argus Research	John Staszak	Upgrade	Hold→Buy	—
Jul 28, 2025	Mizuho	John Baumgartner	PT Raise	Neutral	$8→$9
May 1, 2025	Citigroup	Chasen Bender	PT Cut	Buy	$13→$11
Mar 21, 2025	DA Davidson	Linda Bolton Weiser	Upgrade	Neutral→Buy	$8→$14
Feb 20, 2025	DA Davidson	Linda Bolton Weiser	Maintained	Neutral	$8
Nov 1, 2024	Mizuho	John Baumgartner	PT Raise	Neutral	$8→$9
Oct 31, 2024	DA Davidson	Linda Bolton Weiser	PT Cut	Neutral	$13→$8
Oct 31, 2024	B. Riley Securities	Jeff Van Sinderen	PT Cut	Buy	$17→$12
Oct 25, 2024	Citigroup	Chasen Bender	PT Cut	Buy	$16→$13
Aug 1, 2024	B. Riley Securities	Jeff Van Sinderen	PT Raise	Buy	$16→$17
Aug 1, 2024	DA Davidson	Linda Bolton Weiser	PT Raise	Neutral	$10→$13
Jun 7, 2024	Mizuho	John Baumgartner	PT Raise	Neutral	$10→$11

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Citigroup Maintains Buy on Herbalife, Lowers Price Target to $17

Citigroup analyst Chasen Bender maintains Herbalife (NYSE:HLF) with a Buy and lowers the price target from $21 to $17.

Benzinga Newsdesk

Bill Ackman's 'Baby Buffett' Model Is 'Democratizing Hedge Fund Owneship,' Analyst Says

BofA initiated Pershing Square with a Neutral rating, calling Bill Ackman's firm a "Baby Buffett" model built on permanent capital, retail investing access and long-term compounding.

Piero Cingari

PRO
Mizuho Maintains Neutral on Herbalife, Raises Price Target to $15

Mizuho analyst John Baumgartner maintains Herbalife (NYSE:HLF) with a Neutral and raises the price target from $13 to $15.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Herbalife, Raises Price Target to $21

Citigroup analyst Chasen Bender maintains Herbalife (NYSE:HLF) with a Buy and raises the price target from $17 to $21.

Benzinga Newsdesk

PRO
Mizuho Maintains Neutral on Herbalife, Raises Price Target to $13

Mizuho analyst John Baumgartner maintains Herbalife (NYSE:HLF) with a Neutral and raises the price target from $11 to $13.

Benzinga Newsdesk

PRO
Maxim Group Initiates Coverage On Herbalife with Buy Rating, Announces Price Target of $20

Maxim Group analyst Anthony Vendetti initiates coverage on Herbalife (NYSE:HLF) with a Buy rating and announces Price Target of $20.

Benzinga Newsdesk